<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03973242</url>
  </required_header>
  <id_info>
    <org_study_id>DFHP2018</org_study_id>
    <nct_id>NCT03973242</nct_id>
  </id_info>
  <brief_title>Dual-focus Magnification With Narrow-band Imaging in Helicobacter Pylori Infection</brief_title>
  <official_title>Usefulness of Dual-focus Magnification With Narrow-band Imaging in the Prediction of Helicobacter Pylori Infection: a Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyunghee University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyunghee University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dual-focus with narrow-band imaging (DF-NBI) is a novel technique to improve the quality of
      images of the irregular mucosal structures and microvessels of gastric neoplasms. The
      investigators compare this technique with conventional white light (WL) endoscopy to predict
      Helicobacter pylori infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The subjects are patients who underwent upper gastrointestinal endoscopy under sedation.
      Participants are randomized into DF-NBI and WL groups. Rapid urease test will be performed in
      all cases. By captured images of gastric mucosa, classification of DF-NBI for Helicobacter
      pylori infected mucosa will be developed and validated. The established classification of WL
      for Helicobacter pylori infection will be used. Finally, the investigators will compare the
      accuracy between two groups based on each classification.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study group: Dual Focus with Narrow band imaging Control group: White light endoscopy</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accurate prediction of Helicobacter pylori status</measure>
    <time_frame>1 day</time_frame>
    <description>Sensitivity, specificity, PPV, and NPV</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">292</enrollment>
  <condition>Helicobacter Pylori Infection</condition>
  <arm_group>
    <arm_group_label>DF-NBI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Initially, gastric mucosa is observed by conventional wight light endoscopy. Then, converting to dual-focus mode with narrow band imaging is done. Gastric mucosa is observed once again by DF-NBI mode.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WL</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conventional white light endoscopy use It is routine practice for the upper gastrointestinal endoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dual focus with narrow band imaging</intervention_name>
    <description>dual focus mode for imaging magnification + narrow band imaging for the enhancement of mucosal vascularity and irregularity</description>
    <arm_group_label>DF-NBI</arm_group_label>
    <arm_group_label>WL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consecutive patients who have undergone uper gastrointestinal endoscopy for diagnosis
             or screening of cancer.

        Exclusion Criteria:

          -  Those whose Hp status had already been clarified

          -  Pregnancy

          -  History of partial gastrectomy

          -  Taking proton pump inhibitor, antithrombotics or antibiotics within 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jung-Wook Kim, MD, PhD</last_name>
    <phone>82-2-958-8141</phone>
    <email>iloveact@hanmail.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yoomin Park, MD</last_name>
    <phone>82-2-958-8200</phone>
    <email>uminee@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kyung Hee University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>130-872</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Young Jang, MD, PhD</last_name>
      <phone>82-2-958-8149</phone>
    </contact>
    <investigator>
      <last_name>Jung-Wook Kim, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 31, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2019</study_first_posted>
  <last_update_submitted>May 31, 2019</last_update_submitted>
  <last_update_submitted_qc>May 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyunghee University Medical Center</investigator_affiliation>
    <investigator_full_name>Jung-Wook Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Helicobacter Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>If needed, IPD will be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

